Viewing Study NCT00256295


Ignite Creation Date: 2025-12-24 @ 2:12 PM
Ignite Modification Date: 2026-01-22 @ 8:32 AM
Study NCT ID: NCT00256295
Status: TERMINATED
Last Update Posted: 2017-02-01
First Post: 2005-11-17
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Weekly Oxaliplatin and Gemcitabine for Recurrent or Metastatic Head and Neck Cancer
Sponsor: Sai-Hong Ignatius Ou
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: UCI 04-08
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View